Vitamin E slows progression of Alzheimer´s disease

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

This study evaluated the efficacy of a commonly used medical drug (selegiline) and vitamins in treating Alzheimer´s disease. A total of 341 patients received selegiline, vitamin E, both selegiline and vitamin E or a placebo for two years. It was found that both selegiline and vitamin E were effective in slowing the progression of illness in patients with Alzheimer´s disease. Further details can be found in the study.
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997 Apr 24;336(17):1216-22.



Leave a Reply